Nov 2019

ANTG CRAFTS A PATHWAY TO PROFIT

What’s most important in business – purpose or profit? At ANTG we get to achieve both. Our revenue streams build business sustainability, allowing us to continue to focus on our passion for the plant and the people it can help. Our CEO, Matt Cantelo lays out our pathway to profits. Read the article here.

ANTG appoints new Business Operations Manager   Australian Natural Therapeutics […]

READ MORE >

ANTG’s Eve Cannabis product reveals its potential to kill or inhibit cancer cells without impacting normal cells…

READ MORE >

ANTG has listed two new THC-dominant medicinal cannabis strains on the Australian Register of Therapeutic Goods (ARTG).

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >